Results 21 to 30 of about 21,011 (152)

Intra-Arterial Delivery of Idarubicin in Two Patients with Glioblastoma

open access: yesCase Reports in Oncology, 2016
There is no effective treatment for recurrent glioblastoma (GB) when temozolomide-based radiochemotherapy fails. In theory, intra-arterial (IA) delivery of cytotoxic agents could achieve higher drug concentrations in tumors compared to intravenous ...
Mohamad Chehimi   +6 more
doaj   +1 more source

Daily Cisplatin and Weekly Docetaxel versus Weekly Cisplatin Intra-Arterial Chemoradiotherapy for Late T2-3 Tongue Cancer: A Pilot and Feasibility Trial

open access: yesMedicina, 2018
Background and objectives: The aim of present study was to compare the treatment results of daily cisplatin (CDDP), weekly docetaxel (DOC) intra-arterial infusion chemotherapy combined with radiotherapy (DIACRT) regimen and weekly CDDP intra-arterial ...
Yuichiro Hayashi   +11 more
doaj   +1 more source

Case Report: Clinical application of continuous arterial infusion chemotherapy in neoadjuvant therapy for locally advanced gastric cancer

open access: yesFrontiers in Oncology, 2023
Platinum-fluorouracil combination chemotherapy is the standard neoadjuvant treatment for locally advanced gastric cancer in China, but it does not improve the survival benefit of patients.
Wenli Lin   +4 more
doaj   +1 more source

Retrograde Approach for Intra-arterial Chemotherapy Delivery in Retinoblastoma

open access: yesJournal of Clinical Interventional Radiology ISVIR, 2021
Intra-arterial chemotherapy (IAC) is currently, the first-line treatment for retinoblastomas with successful cure rates. In difficult access or unsuccessful catheterization of the ophthalmic artery (OA), the middle meningeal artery is a second ...
Giancarlo Saal-Zapata   +4 more
doaj   +1 more source

Use of intra-arterial chemotherapy for retinoblastoma:results of a survey [PDF]

open access: yesInternational Journal of Ophthalmology, 2014
AIM: To obtain baseline knowledge about the current use of intra-arterial chemotherapy (SSOAIC) in centers worldwide.METHODS:A survey including questions about the use of SSOAIC was emailed to retinoblastoma experts.RESULTS:Seventy-nine (response rate 69.
Nathalia Grigorovski   +6 more
doaj   +1 more source

Intra-arterial chemotherapy in retinoblastoma – A paradigm change

open access: yesIndian Journal of Ophthalmology, 2019
Intra-arterial chemotherapy (IAC), also known as superselective ophthalmic artery chemotherapy or chemosurgery, is currently widely accepted as one of the primary treatment modalities for intraocular retinoblastoma worldwide.
Fairooz P Manjandavida   +4 more
doaj   +1 more source

Strategies for Improved Intra-arterial Treatments Targeting Brain Tumors: a Systematic Review

open access: yesFrontiers in Oncology, 2020
Conventional treatments for brain tumors relying on surgery, radiation, and systemic chemotherapy are often associated with high recurrence and poor prognosis.
Rui Huang, Johannes Boltze, Shen Li
doaj   +1 more source

Retinoblastoma: Achieving new standards with methods of chemotherapy

open access: yesIndian Journal of Ophthalmology, 2015
The management of retinoblastoma (RB) has dramatically changed over the past two decades from previous radiotherapy methods to current chemotherapy strategies. RB is a remarkably chemotherapy-sensitive tumor.
Swathi Kaliki, Carol L Shields
doaj   +1 more source

Intra-arterial chemotherapy for brain tumors

open access: yesCleveland Clinic Journal of Medicine, 1990
Direct comparisons of theoretical modeling with actual drug delivery can lead to improved brain tumor therapy. In this study, normal and brain tumor-bearing rabbits received infusions of BCNU, or carmustine (1,3-bis [2-chlorethyl]-1-nitrosourea), with ethanol or hyperoxygenated perfluorocarbons as BCNU diluent. When ethanol was used as a diluent, right
B. H. Brouhard   +3 more
openaire   +2 more sources

Bridging the diagnostic and therapeutic gaps in retinoblastoma: A referral center’s perspective from Southeast Asia

open access: yesAJO International
Purpose: To highlight diagnostic and therapeutic disparities in retinoblastoma care and share our institutional approach to bridging these gaps in a resource-limited setting in Southeast Asia. Design: Perspective and selected literature review.
Thanaporn Kritfuangfoo   +1 more
doaj   +1 more source

Home - About - Disclaimer - Privacy